New diabetes clinical trial: Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes
Published on: October 06, 2022 at 11:00AM
Condition: Glucose Intolerance After a Recent History of Gestational Diabetes
Interventions: Drug: Semaglutide Pen Injector; Drug: Semaglutide placebo
Sponsors: Universitaire Ziekenhuizen KU Leuven; UZA; Universitair Ziekenhuis Brussel; General Hospital Groeninge; Onze Lieve Vrouw Hospital; AZ Delta; Jessa Hospital; Ziekenhuis Netwerk Antwerpen (ZNA); Vitaz; Centre Hospitalier Universitaire de Liege; Erasme University Hospital; Centre Hospitalier Mouscron
Not yet recruiting
https://ift.tt/QN9SKYl
Condition: Glucose Intolerance After a Recent History of Gestational Diabetes
Interventions: Drug: Semaglutide Pen Injector; Drug: Semaglutide placebo
Sponsors: Universitaire Ziekenhuizen KU Leuven; UZA; Universitair Ziekenhuis Brussel; General Hospital Groeninge; Onze Lieve Vrouw Hospital; AZ Delta; Jessa Hospital; Ziekenhuis Netwerk Antwerpen (ZNA); Vitaz; Centre Hospitalier Universitaire de Liege; Erasme University Hospital; Centre Hospitalier Mouscron
Not yet recruiting
https://ift.tt/QN9SKYl
Comments
Post a Comment